Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

From Insightful Science to Innovative Health: Strengthening Translational Capacity and Talent Interoperability in Vaccine and Biologic Research & innovation

Descrizione del progetto

Costruire reti globali per i vaccini

La pandemia di COVID-19 ha dimostrato come la gestione di tali minacce sanitarie richieda stretti legami tra ricerca e industria, oltre a solide reti locali per la produzione e la distribuzione dei vaccini. In quest’ottica, il progetto VISION, finanziato dall’UE, riunisce partner provenienti dalla Serbia, dalla Tunisia, dall’Ucraina e da tutta Europa per potenziare le competenze nel campo della scienza dei vaccini attraverso la formazione e la ricerca condivisa. Ciò include strumenti all’avanguardia basati sull’mRNA. Il progetto punta anche a migliorare il modo in cui le fabbriche aumentano la produzione e distribuiscono questi prodotti. Grazie al trasferimento di esperti tra le regioni e alla condivisione dei dati, VISION contribuisce ad accelerare la ricerca. L’obiettivo del progetto è aiutare i paesi più piccoli a diventare centri di eccellenza a livello regionale.

Obiettivo

Following the COVID-19 pandemic, biologicals and vaccines became regarded as salient pillars for disease prevention and control. However, strengthening preparedness for and response to health emergencies request more commitment and intersectoral cooperation between academia and industry to set up efficient strategies against diseases, whether through surveillance, detection, diagnosis, prevention, or treatment. VISION (Vaccine & bIologics reSearch & innovatION) intends to implement an intensive intersectoral and bidirectional knowledge/know-how transfer programs in order to reinforce vaccine and biologics development capacities with manufacturing, upscaling, or delivery capabilities among a consortium with Institut Pasteur de Tunis (Tunisia), Darnitsa (Ukraine), Torlak Institute (Serbia) and Connect’innov (Tunisia) as academic (AC) & non-academic (NA) widening members; Institut Pasteur (France) and Center for Genomic Regulation (Spain) as academic research non widening (NW) organizations, Ciloa (France), ACTG-CRO (France), M4Health (Germany) and iBET (Portugal) as NW&NA partners. VISION comes as a critical lever for R&I ecosystem feeding post-pandemic needs and matches the WHO mRNA Transfer initiative aiming to enhance widening production capacities and help achieving a comprehensive health coverage towards Sustainable Development Goals. VISION will in fine streamline the discovery, testing and production of biologics and vaccine candidates including mRNA-based technologies. VISION's main objectives are threefold: (i) endow Widening Talents with advanced knowledge and skills in Vaccine and Biologics Development, (ii) promote more impactful collaboration through training and mobility between AC and NA sectors towards an efficient high-performance translational R&I environment with an Open Science pillar, and (iii) ambition to make widening members a regional flagship for excellence in innovative research with increased biobusiness and entrepreneurship capacity and openness to the socio-economic sector.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-CSA - HORIZON Coordination and Support Actions

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-WIDERA-2022-TALENTS-03

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

INSTITUT PASTEUR DE TUNIS
Contributo netto dell'UE
€ 1 719 791,25
Costo totale
€ 1 719 791,25

Partecipanti (10)